Literature DB >> 9077497

IL-6 detection in multiple sclerosis brain.

D Maimone1, G C Guazzi, P Annunziata.   

Abstract

By using a double-label immunohistochemistry technique, we demonstrated the presence of interleukin-6 (IL-6) in acute and chronic active plaques from the brain of six patients with multiple sclerosis (MS). IL-6 was mainly associated with astrocytes and rarely with macrophages or mononuclear infiltrating cells. The pattern of distribution for IL-6 immunoreactivity was similar to that of HLA-DR expression, but the two molecules almost never colocalized on the same cell. Our data indicate that in MS central nervous system IL-6 is predominantly located within resident glial cells which are concentrated at the sites of ongoing demyelination and immune activation. Although IL-6 exhibits several proinflammatory activities, indirect evidence suggests that the cytokine may also play an immunomodulatory role in inflammatory demyelinating disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077497     DOI: 10.1016/s0022-510x(96)00283-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  45 in total

1.  The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: another aspect of immune privilege in the CNS.

Authors:  Benjamin M Segal
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

Review 2.  Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.

Authors:  Bharath Wootla; Jens O Watzlawik; Nikolaos Stavropoulos; Nathan J Wittenberg; Harika Dasari; Murtada A Abdelrahim; John R Henley; Sang-Hyun Oh; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Opin Biol Ther       Date:  2016-03-10       Impact factor: 4.388

3.  Erythrina abyssinica prevents meningoencephalitis in chronic Trypanosoma brucei brucei mouse model.

Authors:  Johnson Nasimolo; Stephen Gitahi Kiama; Peter Karuri Gathumbi; Andrew Ndegwa Makanya; John Maina Kagira
Journal:  Metab Brain Dis       Date:  2014-01-23       Impact factor: 3.584

4.  The Spatio-Temporal Expression Profiles of CD4 + T Cell Differentiation and Function-Related Genes During EAE Pathogenesis.

Authors:  Yingying Cai; Hu Shen; Chaoyan Qin; Jinfeng Zhou; Weiming Lai; Juping Pan; Changsheng Du
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

5.  Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.

Authors:  Mario Stampanoni Bassi; Ennio Iezzi; Doriana Landi; Fabrizia Monteleone; Luana Gilio; Ilaria Simonelli; Alessandra Musella; Georgia Mandolesi; Francesca De Vito; Roberto Furlan; Annamaria Finardi; Girolama A Marfia; Diego Centonze; Fabio Buttari
Journal:  J Neurol       Date:  2018-08-28       Impact factor: 4.849

6.  Purkinje neuron physiology is altered by the inflammatory factor interleukin-6.

Authors:  Donna L Gruol; Thomas E Nelson
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 7.  T-cell cytokines in injury-induced neural damage and repair.

Authors:  Michael Schroeter; Sebastian Jander
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

8.  IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes.

Authors:  Sakthi Rajendran; Florence Anquetil; Estefania Quesada-Masachs; Madeleine Graef; Nathaly Gonzalez; Sara McArdle; Tiffany Chu; Lars Krogvold; Knut Dahl-Jørgensen; Matthias von Herrath
Journal:  Clin Immunol       Date:  2019-12-03       Impact factor: 3.969

9.  Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.

Authors:  Christian Hundhausen; Alena Roth; Elizabeth Whalen; Janice Chen; Anya Schneider; S Alice Long; Shan Wei; Rebecca Rawlings; MacKenzie Kinsman; Stephen P Evanko; Thomas N Wight; Carla J Greenbaum; Karen Cerosaletti; Jane H Buckner
Journal:  Sci Transl Med       Date:  2016-09-14       Impact factor: 17.956

10.  Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation.

Authors:  Henrik Wilms; Jobst Sievers; Uta Rickert; Martin Rostami-Yazdi; Ulrich Mrowietz; Ralph Lucius
Journal:  J Neuroinflammation       Date:  2010-05-19       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.